NOVEL TREATMENT APPROACHES IN REACTIVE ARTHRITIS: CLINICAL AND CYTOKINE RESPONSES TO IGURATIMOD 25 MG COMPARED WITH BIOLOGIC AND CONVENTIONAL THERAPIES. JUSR. 2025;1(Maxsus son (FARMAKOLOGIYA, FARMATSEVTIKA):86-86. doi:10.66301/jusr.v1i0.14971